Revolution Analytics
 |
|
| Subsidiary | |
| Industry | Statistical software |
| Predecessor | Revolution Computing |
| Founded | 2007 |
| Headquarters | Mountain View, CA, United States |
|
Key people
|
David Rich, CEO |
| Products | Revolution R |
| Revenue | 8-11 Million in 2009 |
| Owner | Microsoft |
| Parent | Microsoft |
| Website | revolutionanalytics.com |
Revolution Analytics (formerly REvolution Computing) is a statistical software company focused on developing open source and "open-core" versions of the free and open source software R for enterprise, academic and analytics customers. Revolution Analytics was founded in 2007 as REvolution Computing providing support and services for R in a model similar to Red Hat's approach with Linux in the 1990s as well as bolt-on additions for parallel processing. In 2009 the company received nine million in venture capital from Intel along with a private equity firm and named Norman H. Nie as their new CEO. In 2010 the company announced the name change as well as a change in focus. Their core product, Revolution R, would be offered free to academic users and their commercial software would focus on big data, large scale multiprocessor (or "high performance") computing, and multi-core functionality.
Microsoft announced on January 23, 2015 that they had reached an agreement to purchase Revolution Analytics for an as yet undisclosed amount.
REvolution Computing was founded in New Haven, Connecticut in 2007 by Richard Schultz, Martin Schultz, Steve Weston and Kirk Mettler. At the time Martin Schultz was also the Watson Professor of Computer Science at Yale University. Adding parallel computing to R allowed the company to net large gains in speed for many common analytics operations and early clients like Pfizer took advantage of REvolution R to see large performance gains using R on computing clusters. While the improvements to core R were released under the GNU General Public License (GPL), REvolution provides support and services to customers of their commercial product and had considerable early success with life sciences and pharmaceutical companies. A year later the company opened an additional office in Seattle.
...
Wikipedia